CMRL-1066 Medium

 

The CMRL is a nucleosid- and vitamin-rich medium. In the past it was developed to clone monkey-kidney cells and as long time culture medium for L-cells. It is suitable for many types of human and monkey cells and also for other mammalian cells, especially by using horse and calf serum.

 


DescriptionSizeProduct number
CMRL – 1066
without L-Glutamine
without Phenol red
with 2.2 g/L NaHCO3
500 ml ST04-84600
 

 


DescriptionSizeProduct number
CMRL – 1066
with L-Glutamine
without Phenol red
with 2.2 g/L NaHCO3
500 ml ST04-84500
 
Minimum order 20 pieces

 Componentsmg/L
Inorganic Salts Calcium chloride x 2H2O
Potassium chloride
Magnesium sulfate dried
Sodium acetate anhydrous
Sodium chloride
Sodium dihydrogen phosphate x H2O
264,92
400,00
97,67
50,00
6.800,00
140,00
Other Components




Cholesterol
D(+)-Glucose anhydrous
Glutathione (red.)
Sodium glucuronate x H2O
Tween 80
0,20
1.000,00
10,00
3,88
5,00
Coenzyme




Cocarboxylase x HCl
Coenzyme A Trilithiumsalt x 2H2O
NAD
NADP sodium salt
UTP
1,00
2,60
7,00
1,00
1,00
Amino Acids




















L-Alanine
L-Arginine x HCl
L-Aspartic acid
L-Cysteine x HCl x H2O
L-Cystine
L-Glutamine
L-Glutamic acid
Glycine
L-Histidine x HCl x H2O
L-Hydroxyproline
L-Isoleucine
L-Leucine
L-Lysine x HCl
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
25,00
70,00
30,00
260,00
20,00
100,00
75,00
50,00
20,00
10,00
20,00
60,00
70,00
15,00
25,00
40,00
25,00
30,00
10,00
40,00
25,00
Vitamins












L-Ascorbic acid
P-Aminobenzoic Acid
D(+)-Biotin
D-Calcium pantothenate
Choline chloride
Folic acid
myo-Inositol
Nicotinic Acid
Nicotinamide
Pyridoxal x HCl
Pyridoxine
Riboflavin
Thiamine x HCl
50,00
0,05
0,01
0,01
0,50
0,01
0,05
0,025
0,025
0,025
0,025
0,01
0,01
Deoxyribonucleosides




2`-Deoxyadenosine x H2O
2`-Deoxycytidine x HCl
2`-Deoxyguanosine
2`-Deoxythymidine
5-Methyl-2`-deoxycytidine
Flavin adenine dinucleotide Na2- Salt
10,00
11,00
10,00
10,00
0,10
0,106
 
This website use cookies to create the most secure and effective website. By continuing to use this website you agree that cookies are used.
More information Ok